Association Between Oxidative Parameters in Fertilization Medium of Cumulus Oocyte Complex and Outcome in IVF
Sponsor
Carmel Medical Center (Other)
Overall Status
Unknown status
CT.gov ID
NCT03382002
Collaborator
(none)
322
1
29
11.1
Study Details
Study Description
Brief Summary
Medium of cumulus-oocyte complex will be assessed for oxidative status.
| Condition or Disease | Intervention/Treatment | Phase |
|---|---|---|
|
Study Design
Study Type:
Observational
Anticipated Enrollment
:
322 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
Evaluation of Association Between Oxidative Parameters in Fertilization Medium of Cumulus Oocyte Complex (COC( as Measured by the TCL Assay and Clinical and Laboratory Outcome Parameters in IVF
Actual Study Start Date
:
Nov 28, 2017
Anticipated Primary Completion Date
:
Nov 28, 2019
Anticipated Study Completion Date
:
Apr 28, 2020
Outcome Measures
Primary Outcome Measures
- Association of parameters of oxidative state with cycle outcome (pregnancy: yes/no) [two years]
The oxidative status in the incubation medium of the cumulus-oocyte complex will be assessed looking for an association between oxidative parameters and cycle outcome (pregnancy: yes/no))
Eligibility Criteria
Criteria
Ages Eligible for Study:
18 Years
to 45 Years
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
No
Inclusion Criteria:
•Patients undergoing in vitro fertilization treatment
Exclusion Criteria:
•Patients undergoing intracytoplasmic sperm injection
Contacts and Locations
Locations
| Site | City | State | Country | Postal Code | |
|---|---|---|---|---|---|
| 1 | Carmel medical Center | Haifa | Israel |
Sponsors and Collaborators
- Carmel Medical Center
Investigators
None specified.Study Documents (Full-Text)
None provided.More Information
Publications
None provided.Responsible Party:
Zofnat Wiener,
Principal investigator,
Carmel Medical Center
ClinicalTrials.gov Identifier:
NCT03382002
Other Study ID Numbers:
- CarmelMC
First Posted:
Dec 22, 2017
Last Update Posted:
Feb 1, 2019
Last Verified:
Jan 1, 2019
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No